BetterLife Pharma BETRF
OTC BETRF
$0.18 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

BetterLife Pharma (BETRF) Non Operating Income (2022 - 2026)

Updated

BetterLife Pharma (BETRF) reported Non Operating Income of -$591,283 for fiscal Q2 2027 (quarter ended Jul 31, 2026), compared with $12,877 a year earlier.

Analysis

BetterLife Pharma (BETRF) Non Operating Income (2022 - 2026) Analysis & Trends

Over the twelve months ended Jul 31, 2026, BetterLife Pharma's Non Operating Income came in at -$510,508; for FY2026 (ended Jan 31, 2026), it was $68,106, down 93.2% from FY2025.

  • By fiscal year, Non Operating Income came in at $1 million in FY2025 (+295.0%), $253,337 in FY2024 (+276.7%), $67,249 in FY2023 and -$1.42 million in FY2022.
  • The fiscal Q2 2027 figure ranks as the lowest quarterly Non Operating Income since fiscal Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 269.00 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -73.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 387.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 BetterLife Pharma 27.34 Mn 28.95 Mn - -591,282.83
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 -591,282.83
Apr 30, 2026 -20,063.60
Jul 31, 2025 12,877.43
Apr 30, 2025 72,823.07
Apr 30, 2023 -93,682.61
Apr 30, 2022 51,132.38
API Access

BetterLife Pharma Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=BETRF&period=max&api_key=YOUR_API_KEY